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Ying Zhang,a Herbert J. Tobias,a Richard J. Auchusb† and J. Thomas Brennaa*Comprehensive 2-dimensional gas chromatography (GCGC), coupled to either a time of ﬂight mass spectrometry (TOF-MS)
or a fast scanning quadrupole MS (qMS) has greatly increased the peak capacity and separation space compared to
conventional GC-MS. However, commercial GCGC-TOFMS systems are not equipped with chemical ionization (CI) and do
not provide dominant molecular ions or enable single ion monitoring for maximal sensitivity. A GCGC-qMS in mass
scanning mode was investigated with electron ionization (EI) and positive CI (PCI), using CH4 and NH3 as reagent gases.
Compared to EI, PCI-NH3 produced more abundant molecular ions and high mass, structure-speciﬁc ions for steroid acetates.
Chromatography in two dimensions was optimized with a mixture of 12 endogenous and 3 standard acetylated steroids
(SM15-AC) relevant to doping control. Eleven endogenous target steroid acetates were identiﬁed in normal urine based on
their two retention times, and EI and PCI-NH3 mass spectra; nine of these endogenous target steroid acetates were identiﬁed
in congenital adrenal hyperplasia (CAH) patients. The difference between the urinary steroids proﬁles of normal individuals
and those from CAH patients can easily be visually distinguished by their GCGC-qMS chromatograms. We focus here on
the comparison and interpretation of the various mass spectra of the targeted endogenous steroids. PCI-NH3 mass spectra
were most useful for unambiguous molecular weight determination and for establishing the number of -OH by the losses
of one or more acetate groups. We conclude that PCI-NH3 with GCGC-qMS provides improved peak capacity and
pseudomolecular ions with structural speciﬁcity. Copyright © 2011 John Wiley & Sons, Ltd.
Keywords: anabolic androgenic steroids; comprehensive 2-dimensional gas chromatography; quadrupole mass spectrometry; electron
impact ionization; positive chemical ionization* Correspondence to: J. Thomas Brenna, Cornell University, Division of Nutritional
Sciences, Savage Hall, Ithaca, NY 14853, USA.
E-mail: jtb4@cornell.edu
† Current Address: University of Michigan Medical Center, 1150 WMedical Center
Drive, Ann Arbor, MI, 48109, USA
a Cornell University, Division of Nutritional Sciences, Ithaca, NY, USA
b University of Texas Southwestern Medical Center, Dallas, TX, USA
8
5
7Introduction
Gas chromatography electron ionization mass spectrometry
(GC-(EI)-MS) has been used to test for anabolic androgenic ste-
roids (AAS) in antidoping tests since the ﬁrst use of capillary col-
umns for steroid analysis was published by Vollmin in 1972.[1]
The development of GC-(EI)-MS showed steady progress over
these years resulting in the inexpensive and robust bench-top
systems in use today. However, GC-(EI)-MS analysis of complex
mixtures of steroids extracted from urine is limited by separa-
tion efﬁciency and production of ions characteristic of the
molecular weight.[2–9] Alternatively, GC coupled to tandem
MS (GC-MS/MS) has improved detection limits and used for
compound identiﬁcation in steroid analysis in recent years,
but still requires targeted analysis.[10–13]
The development of comprehensive 2-dimensional GC (GC
GC), coupled to either a time of ﬂight MS (TOF-MS) or a fast
scanning quadrupole MS (qMS) has greatly increased the peak
capacity and separation space to improve analysis of complex
samples. GCGC employs two columns in tandem with orthog-
onal stationary phases, where the ﬁrst column separates normally
(~30–60min) and the second column separates cryogenic
trapped slices that are released after the ﬁrst column very rapidlyDrug Test. Analysis 2011, 3, 857–867(every 2–10 s). GCGC generally results in an order-of-magnitude
increase in separation capacity over traditional GC and an increase
in signal to noise (S/N) when used with a cryogenic modulator. In
recent years, GCGC-TOFMS has been explored for steroid
analysis.[14–17] The signiﬁcantly less expensive and smaller footprint
GCGC-qMS has the advantage of additional technical capabilities,
such as positive chemical ionization (PCI) and negative chemical
ionization (NCI). GCGC-qMS has been successfully applied to
analysis of bacterial lipids,[18] environmental contaminants,[19]
essential oils,[20] and gasoline[21] using electron ionization (EI).
PCI-MS emerged from pioneering work on ion/molecule reac-
tions in the 1960s by Munson and Field.[22] It is now an optionalCopyright © 2011 John Wiley & Sons, Ltd.
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8feature on many commercially available mass spectrometers and
is performed using reagent gas plasmas to ionize sample mole-
cules. For the generation of positive ion mass spectra, the most
common reagent gases are CH4, C4H10, and NH3. In PCI, the
reagent gas is ionized by EI, followed by ion-molecule reactions
that produce primary and secondary reagent ions such as CH5
+
and C2H
þ
5 with CH4, C3H
þ
7 C4H
þ
9 with C4H10 and NH
þ
4 with NH3,
all of which are excellent proton donors. These ions react with
the analyte molecules (M), in fast acid/base reactions, or subse-
quently fragment to yield a limited number of product ions.[23]
CH4 is the strongest proton donor commonly used, with a proton
afﬁnity (PA) of 546 kJ/mol. For softer ionization, isobutane (C4H10 ;
PA= 824 kJ/mol) and NH3 (PA= 858 kJ/mol) are frequently
used.[24] Due to the lower excess energy transfer than in EI, PCI
produces simpler mass spectra with less molecular fragmentation
and more abundant and easily identiﬁable molecular ions than EI.
PCI mass spectra concentrate more ion signal in fewer m/z peaks
and aids in molecular weight determination due to the intense
(pseudo)-molecular ions formed from protonation [M+H]+,
hydride abstraction [M-H]+, or adduct formation [M+NH4]
+ for
ammonia that are typically observed.
Early on, Lin et al.[23] reported PCI-MS of free steroids using
ammonia as reagent gas ((PCI-NH3)-MS) and showed simple ions
that provide information about molecular weight, as well as
functionalities in the molecules for cholesterol and its derivatives
in 1980. Subsequently, Lusby et al.[2] presented (PCI-NH3)-MS as
the method of choice for MS analysis of sterol esters after compar-
ison of three reagent gases, CH4, C4H10, and NH3. In 1992, Rezanka
et al.[25] demonstrated that more than 30 sterols in a complex sam-
ple, such as alga and yeast, can be detected using (PCI-NH3)-MS
due to its high sensitivity and abundant molecular ion information.
Here we report an evaluation of a novel commercial GCGC
coupled to fast qMS with PCI-NH3 (GCGC-(PCI-NH3)-qMS) to
analyze complex urinary steroid extract samples with high
speciﬁcity as a potentially useful technique for an untargeted
screening of urinary steroid proﬁles. Urinary steroid preparation
methods common to antidoping analysis are applied to test
human urine samples.
Experimental
Chemicals and standard mixtures
High purity He (99.999%) and NH3 (99.9995%) were purchased
from Airgas East (Salem, NH, USA). High purity CH4 (99.999%)
was purchased from Matheson Tri-Gas (Twinsburg, OH, USA). A
mixture of 15 steroids shown in Table 1 (SM15) was prepared.
Twelve target endogenous steroids were used: 5b-androstan-3a-
ol-17-one (etiocholanolone, E), 5a-androstan-3a-ol-17-one (andros-
terone, A), 5-androsten-3b-ol-17-one (dehydroepiandrosterone,
DHEA), 5b-androstan-3a-ol-11, 17-dione (11-ketoetiocholanolone,
11KE), 5a-androstan-17b-ol 3-one (dihydrotestosterone, DHT),
5b-androstan-3a, 17b-diol (5bA), 5a-androstan-3a, 17b-diol (5aA),
4-androsten-17a-ol-3-one (epitestosterone, EpiT), 4-androsten-
17b-ol-3-one (testosterone, T), 5a-androstan-3a, 11b-diol-17-one
(11b-hydroxyandrosterone, 11-OHA), 5b-pregnane-3a,20a-diol (5b-
pregnanediol, 5bP), and 5b-estran-3a-ol-17-one (19-Noretiocholano-
lone, 19NE). One endogenous steroid normally present in urine at
low concentration as a glucuronide conjugate, 5a-androstane-3b-
ol-17-one (epiandrosterone, EpiA), and two exogenous steroids,
5a-androstan-3b-ol (5a-androstanol) and 5a-cholestane (Cne),
were used as internal standards. Other steroid standards were:wileyonlinelibrary.com/journal/dta Copyright © 2011 John Wiley & Sons, Ltd. Drug Test. Analysis 2011, 3, 857–867
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and Analysis5b-pregnane-3a, 17,20a-triol (pregnanetriol), 5b-pregnane-3a,
17, 20a-triol-11-one (pregnanetriolone), 5-pregnen-3b, 17-diol-20-
one (17a-hydroxypregnenolone), and 4-pregnen-17-ol-3, 20-dione
acetate (17a-progesterone-AC). All steroids were of 99% purity,
and were purchased from Steraloids (Newport, RI, USA) and used
without further puriﬁcation. SM15 structures, molecular weight
(MW), their acetate molecular weight (MWAC) are shown in Figure 1.
ChromabondW C18 cartridges (500mg, 6ml) were obtained from
Macherey-Nagel (Bethlehem, PA, USA). HPLC grade 2-propanol
and methanol were obtained from Mallinckrodt Baker (Phillipsburg,
NJ, USA). The steroid mixture was prepared in HPLC grade 2-
propanol at a concentration of 2 ng/ml for each steroid in the
mixture. Pyridine, acetic anhydride, tert-butylmethylether (TBME),
b-glucuronidase from Escherichia coli, sodium phosphate buffer
(0.2M, pH=7), and potassium carbonate buffer (K2CO3/KHCO3 1:1,
w/w, 200g/l) were purchased from Sigma-Aldrich (St Louis, MO,
USA). All solvents and reagents were of analytical grade.
SM15 was prepared by dissolving an equal amount of each
steroid (~1mg) in 1ml 2-propanol and diluted to a concentration
of 100 ng/ml. A 200 ml aliquot of SM15 (100 ng/ml) was dried under
nitrogen, acetylated by adding 100ml pyridine and 100 ml aceticHO
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Figure 1. Chemical structures of the SM15 native steroids.
Drug Test. Analysis 2011, 3, 857–867 Copyright © 2011 John Wanhydride and heated at 60 C for 1 h, evaporated to dryness
under nitrogen, and then reconstituted into 200ml of 2-propanol.
The acetylated SM15 acetate (SM15-AC) was further diluted 50-fold
to 2 ng/ml in 2-propanol, and 1 ul injection into GCGC-qMS
for analysis.
Urinary steroid sample preparation
Collection and use of human urine was approved by the Institu-
tional Review Boards of the University of Texas Southwestern
Medical Center and Cornell University. Urine (25–80ml) was
obtained from each of ﬁve normal healthy male subjects, be-
tween the ages of 20 and 50 years, and each of three congenital
adrenal hyperplasia (CAH) female subjects, 23, 27, and 30 years
old undergoing long-term therapeutic treatment with various
combinations of hydrocortisone, ﬂudrocortisone (9a-ﬂuorocortisol),
and an oral contraceptive (YasminW, drospirenone 3mg+ethinyl
estradiol 0.03mg). After urine collection, samples were immediately
frozen at 20 C and remained so until sample preparation.
A 20-ml aliquot of each urine sample was prepared for anal-
ysis. The urine samples were prepared by extracting steroidOH
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0glucuronides using solid phase extraction (SPE) and liquid-
liquid extraction, followed by enzymatic hydrolysis to produce
free steroids and derivatized by acetylation, as described by
Piper et al.[26] and Zhang et al.[27] No other clean-up was
performed on the steroid extract samples.
Samples were spiked with an internal standard, EpiA glucuronide
(100ml of 20ng/ml) prior to the SPE step. Another internal standard,
Cne (100ml of 20ng/ml) was added quantitatively prior to injection
of the samples into the GCGC-qMS. These two internal standards
were spiked into all the prepared urine extracts to account for
extraction efﬁciency and instrumental variations.GCGC conﬁguration
All steroid analyses were carried out on a Shimadzu GCGC
QP2010 Ultra quadrupole MS system (Shimadzu, Columbia,
MD, USA) equipped with an AOC-20i autoinjector and a
split/splitless inlet (300 C). GC column 1 was a 30m 0.25mm
i.d.  1.0mm ﬁlm ZB-1ms (100% dimethylpolysiloxane, Phenom-
enex, Torrance, CA, USA) and GC column 2 was a 1.5m 0.1mm
i.d.  0.1mm ﬁlm BPX50 (50% phenyl polysilphenylene-siloxane
50% dimethylpolysiloxane, SGE, Austin, TX, USA), both ﬁtted in a
single GC oven. The GC oven temperature program was 70 C for
1min, ramped at 40 C/min to 300 C, held for 35min, ramped at
40 C/min to 340 C and held for 5min. Helium carrier, with an initial
head pressure of 377 kPa at 70 C, was used at a constant ﬂow rate of
1.3ml/min. Samples were injected into a split/splitless inlet held at
300 C in splitless mode. The modulation was 6 s using a ZoexPCI-NH
EI TIC 
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Figure 2. GCGC-qMS total ion chromatogram (TIC) of a typical normal ur
wileyonlinelibrary.com/journal/dta Copyright © 2011 Jodouble focusing loop modulator (Zoex Corp., Houston, TX, USA)
consisting of a 1.5m 0.1mm i.d. capillary. The nitrogen gas cold
jet was operated at ~125 C to trap steroids, and the hot jet pulse
was operated at 350 C for plug release.
A fused silica capillary (1m 0.1mm i.d.) was used as a transfer
line to the MS.MS parameters
The samples were analyzed in the mass scanning mode at 25Hz
(25 full scans per second), with a scan speed of 10 000 u/s and
with mass ranges of 50–390 u for EI, 70–420 u for PCI-CH4, and
200–440 u for PCI- NH3 at a detector voltage of 0.8 V. The ion
source temperature for EI was 290 C with EI energy of 70 eV,
for PCI-CH4 and PCI-NH3 was 250 C. The NH3 and CH4 gas
pressures were 30 psi and 35 psi, respectively. Shimadzu GC-MS
solution software version 2.53 and GC image software (Zoex
Corp.), version 2.1 were used for data analysis and construction
of GCGC chromatograms.Results and discussions
GCGC-qMS chromatographic separation of urinary steroids
GCGC-qMS chromatographic conditions were optimized using
SM15-AC to achieve best separation of target steroids. Figure 2
presents a total ion chromatogram (TIC) of endogenous steroids
in a urine extract analyzed by GCGC-qMS using EI (Figure 2a)3 TIC 
 (1% volume of 2mL Urine Extract)
-AC
A-AC
AC Cne
(IS)
5 P-AC
11OHA-AC
 (1% volume of 2mL Urine Extract)
A-AC
C
Cne
(IS)
5 P-AC
11OHA-AC
n Time (min)
ine extract using (a) EI and (b) PCI-NH3.
hn Wiley & Sons, Ltd. Drug Test. Analysis 2011, 3, 857–867
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and Analysisand PCI-NH3 (Figure 2b). All target steroids are detected by PCI-
NH3 except for 19NE, which is seldom detected in male urine.
[28]
All detected target steroids are baseline resolved, apart from DHT
and 5aA-diAC which coelute with matrix interference.
CAH refers to autosomal recessive diseases resulting from
mutations of genes for enzymes mediating the biochemical steps
of production of cortisol and aldosterone from cholesterol by the
adrenal glands (steroidogenesis). It involves excessive or deﬁcient
production of sex steroids and can alter development of primary
or secondary sex characteristics in some affected infants, children,
or adults of both genders, and early diagnosis is considered impor-
tant for treatment.[29,30] The three CAH patients were treated with
various binary combinations of hydrocortisone, ﬂudrocortisone,G
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Figure 3. GCGC-qMS TIC of (a) EI and (b) PCI-NH3 in a typical CAH pati
m/z=259, 276, 336).
Drug Test. Analysis 2011, 3, 857–867 Copyright © 2011 John Wand oral contraceptive; thus, CAH symptoms and steroid metabo-
lites were altered in unpredictable ways. Figure 3 shows a typical
GCGC-qMS analysis of endogenous steroids in an extract of urine
from a female patient with CAH, and indicates similar chromato-
graphic separation for target endogenous steroids observed for the
male athletes. In contrast to urine of healthy males, a peak is found
at the retention times for 19NE-AC, an endogenous steroid which
is occasionally found in women’s urine, and may be due to degrada-
tion of E. Figure 3c shows an EIC (m/z 259, 276, 336) characteristic
of 19-nor steroid acetates including 19NE. The inset shows that
19NE-AC, identiﬁed by its mass spectrum and retention time, is
baseline resolved from two adjacent peaks presumed to be isomers
of 19NE-AC based on their similar mass spectra.Cne
5
A-AC
n Time (min)
A-AC
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iley & Sons, Ltd. wileyonlinelibrary.com/journal/dta
8
6
1
Y. Zhang et al.
Drug Testing
and Analysis
8
6
2The TIC chromatographic patterns for the ﬁve normal urine
samples and the three CAH urine samples are generally consis-
tent within each group, reﬂecting expected inter-individual vari-
ability in absolute steroid concentrations. A dramatic difference
is apparent between the TIC steroid patterns (using both EI and
PCI-NH3) of normal urine and CAH urine by comparison of the
GCGC-qMS chromatograms presented in Figures 2 and 3. Ob-
vious manifestations of this difference lie in a few large peaks as
labelled peak 1, peak 2, peak 3, and peak 4 in red circles as shown
in Figures 3a and 3b. Peaks 1, 2, and 4 are not found in normal
urine, while peak 3 is at higher concentration than normal urine.
From PCI-NH3 mode, their molecular weight (MW) and number of
–OH groups was readily apparent; peak 1 has a MW=376 amu
and 2 –OH groups, and peak 2 has a MW=342 amu and one –OH
group. The MW of peaks 3 and 4 are uncertain because of the lim-
ited PCI-NH3 mass scan range, m/z 220–440. Based on the loss of
acetates in other spectra, a plausible MW of peak 3 is m/z
462 amu (3 –OH); two –OHs for peak 3 would not match observed
losses. The peak 4 mass spectrum (not shown) is consistent with
MW=476 amu (3 –OH) or MW=416 amu (2 –OH). CAH is usually
associated with 21-hydroxylase deﬁciency (21-HOD), and diagnosisPCI-NH3 
DHT-AC
(i)
PCI-CH4
DHT-AC
(h)
PCI-NH3 
EpiT-AC
(c)
124 147
91 105 20755 228185159 2
(d)
PCI-CH4
T-AC (e)
124 147
PCI-NH3 
T-AC
(f)
(g)14955 9481
207
124 161 231
PCI-CH4
EpiT-AC
(b)
147 207124 161
147
91 12410555
228207185
(a)
[MH - 60]+
[MH - 60]+
[MH -60-18]+
[MH - 60]+25
50
75
100
25
50
75
100
R
el
at
iv
e 
Ab
un
da
nc
e 
(%
)
25
50
75
100
25
50
75
100
25
50
75
100
25
50
75
100
25
50
75
100
25
50
75
100
25
50
75
100
50 100 150 200
Figure 4. EpiT-AC, T-AC (in normal urine extract), and DHT-AC (in SM15-
50–390 amu), (b, e, h) PCI with methane reagent gas (PCI-CH4) (mass range m
range m/z 220–440 amu). PCI-NH3 results in a very strong relative intensity
assignment of molecular weight identiﬁcation.
wileyonlinelibrary.com/journal/dta Copyright © 2011 Jois by measurement of elevated urinary 17a-hydroxyprogesterone
metabolites pregnanetriol and pregnanetriolone, and as well
as 17-ketosteroids such as A, E, 11-KE, 11-OHA and DHEA,
present in our SM15 mixture.[29–33] Our results show no obvious
elevation of the 17-ketosteroids in the CAH urine samples. Three
acetylated steroid standards, pregnanetriol-AC (MW=462, 3 -AC),
pregnanetriolone-AC (MW=476, 3 -AC), and17a-hydroxypregneno-
lone-AC (MW=416, 2 -AC) have the same MWs as estimated for the
unknown peaks 3 and 4 assuming all –OH groups are amenable to
acetylation. They were investigated using EI mode; however, none
eluted within our GCGC temperature program. The precursor
17a-progesterone, normally measured in serum, also did not elute
as the acetate under our chromatographic conditions. Peak 2 has
a single unique mass spectrum and is thus one long tailing
compound. The cause of this chromatographic phenomenon is
not clear, but may be due to column overloading for this
compound. These unexpected large peaks and bands are consistent
and reproducible in the other two CAH samples and their structures
have not yet been positively identiﬁed. However, the untargeted
nature of the technique, where full mass scans are available at
every pixel provides abundant structural information without350
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for the MW+18 ([M+NH4]
+) or MH+ mass ion, providing unambiguous
hn Wiley & Sons, Ltd. Drug Test. Analysis 2011, 3, 857–867
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and Analysisrequiring reanalysis, as is discussed below. An advantage of GC
GC is that the peak patterns can be easily visualized by 2D contour
plots or 3D plots, which could deﬁne steroid patterns suggestive of
certain clinical maladies, such as endrocrinological disorders, and is
a rapid visual way to monitor the effects of medical treatments or
changes in an individuals metabolic processes due to nefarious dop-
ing practices. Following temporal changes in urinary proﬁles via the
biological passport concept is likely to be useful as a non-targeted
approach to detect use that inﬂuence steroid proﬁles.[34,35]
In reference to the chromatograms in Figures , 2a, 2b, 3a,
and 3b, automatic peak detection of components using PCI-
NH3 appears to be more speciﬁc than using EI due to the
nature of protonation by reagent NH3 gas, where a total of
approximately 1800 and 1200 peaks (i.e. compounds) were
detected using EI and PCI-NH3, respectively, in both urine
samples. For instance, the hydrocarbons highlighted in the
red box in Figure 2a are detected in EI but not detected in
PCI-NH3, thereby producing a cleaner and more speciﬁc
chromatogram. This is advantageous and suitable for steroid
detection in complex urine matrices since endogenous ste-
roids generally have functional groups (OH/-C =O) with
higher proton afﬁnity (PA) than NH3, resulting in efﬁcient
ionization using PCI-NH3.50 100 150 200 2
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Drug Test. Analysis 2011, 3, 857–867 Copyright © 2011 John WPCI mass spectra
The EI, PCI-CH4, and PCI-NH3 mass spectra (MS) for the twelve
target endogenous acetylated steroids detected in urine and
other steroids in SM15-AC are presented in Figures 4–8. Gener-
ally, the EI MS of all steroid acetates are dominated by fragments
with most signals concentrated at low masses and little to no
molecular ion signal, precluding molecular weight determination
of unknowns. On the other hand, the PCI-NH3 MS generally
contain abundant (pseudo)molecular ion signals and a few high
mass fragment ions that are easily interpretable for structural
information, while PCI-CH4 MS contain similar useful ion signals
in many cases. PCI-NH3, with its high PA (~870 kJ/mol
24) and
low energy transfer in ion-molecule reactions, forms abundant
adduct m/z ions [M+NH4]
+ for compounds with many electro-
negative functional groups, as well as protonated molecular ions
[MH]+, which together (difference of 17 mass units) conﬁrm un-
ambiguous molecular weight determination. The acetylating of
the steroids assists in functional group information where abun-
dant fragments associated with the acetate loss are easily identi-
ﬁed and indicate the number of hydroxyl groups present in the
native (underivatized) steroid. These fragments were manifested
as single acetate loss ions [MH - CH3COOH]
+ (or [MH - 60] +),50 300 350 400 450
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4partial acetate loss ions [MH - CH3CO]
+ (or [MH - 43] +), and
double acetate loss ions [MH – 2CH3COOH] + (or [MH - 120] +).
In addition, these signals are often associated with water loss ions
such as [MH - 18] + and [MH – 60–18] +. PCI-CH4 produced some of
the same acetate loss ions; however, seldom produced any
(pseudo) molecular ions. The EI process also produced acetate loss
ions in the form of [M - 60] +.
All the isomeric steroids in SM15 can be differentiated by GC
GC retention times, and in some cases, by their mass spectra.
Figure 1 depicts the structures of all the steroids analyzed in this
work and shows the nomenclature of rings and position numbers
in the steroid perhydrocyclopentanophenanthrene system, using
Cne as the model. H, CH3, OH, and CH3COO groups that lie above
the plane of the ring system are drawn with solid wedges and
designated as b substituents, while those that lie below the plane
are drawn with dashed wedges and designated as a substituents,
and are important for stereochemical designations. For instance,
EpiT-AC and T-AC are diastereoisomers that differ only at the 17
CH3COO position, where EpiT-AC is 17a and T-AC is 17b (Figure 1).
In fact, as shown in Figure 4c and 4f, EpiT-AC and T-AC are the
only steroids that resulted in an MS (using PCI-NH3) where
practically all signal appeared as a single m/z ion, the [MH]+ ion
at m/z 331, which is advantageous for increased sensitivity whenwileyonlinelibrary.com/journal/dta Copyright © 2011 John Wiley & Sons, Ltd. Drug Test. Analysis 2011, 3, 857–86targeted SIM would be performed. In the PCI-NH3 process, the
protonation of a substrate molecule under PCI-NH3 conditions
is measurable only if its proton afﬁnity (PA) is greater than that
of NH3.
[24] Thus here, the ions characteristic of the intact steroid
acetate molecule depend upon the PA of the molecule.
Westmore et al.[24] reported that when 787 kJ/mol< PA (analyte)
PA (NH3), [M+NH4]
+ will be observed; when PA (analyte)> PA
(NH3), both [M+NH4]
+ and [MH] + can be formed, with the
[M+NH4]
+ / [MH] + ratio decreasing as PA (analyte) increases. In
Table 1, EpiT-AC and T-AC have the lowest [M+NH4]
+ / [MH] +
ratio (=0.03), which indicate their PA are the largest in SM15-AC.
This could be explained by their unique conjugated ketone
group which stabilizes the molecule, making it resistant to
deprotonation (more basic), and resulting in more intense
protonation by the reagent gas; as a result [MH] + was produced
almost exclusively over [M+NH4]
+.
On the other hand, DHT-AC has the structure of T-AC, except
the A ring is saturated (i.e. no double bond). This difference is
reﬂected in the PCI-CH4 and PCI-NH3 MS (Figures 4h and 4i),
where the [MH] + (m/z 333) is greater than for EpiT-AC and
T-AC by 2 mass units; however, the PCI-NH3 MS of DHT
contains relatively more [M+NH4]
+ signal ([M+NH4]
+ / [MH] +=
2.4) and demonstrates how a structural difference can alter7
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5the PCI-NH3 process. Although EpiT-AC and T-AC cannot be
differentiated by their PCI-NH3 MS alone, a consistently stron-
ger m/z 147 thanm/z 124 ion signal for EpiT-AC in the EI (Figures 4a
and 4d) and PCI-CH4 MS (Figures 4b and 4e) can be used with
their substantially different GCGC retention times to provide
conﬁdent assignments.
PCI-NH3 MS of EpiT-AC (Figure 4c) and T-AC (Figure 4f) does
not provide functional group information, but the PCI-CH4 does
(Figures 4b and 4e), where in addition to a [MH]+ ion (m/z 331),
a [MH-60] + ion (m/z 271) due to a loss of a complete acetate
group, reveals the steroids to be monoacetates or have a single
hydroxyl group in their native state. Presumably due to its
saturated ring system, both PCI-CH4 (Figure 4h) and PCI-NH3 MS
(Figure 4i) of DHT-AC provide fragment ions that reveal the
presence of a single acetate group. EpiT-AC, T-AC, and DHT-AC
are the only steroid acetates in SM15 that contain a ketone group
at position 3 and for which PCI-CH4 produced a [MH]
+ ion and
methane cluster adduct ions [M+C2H5]
+ (or [M+ 29]+) and
[M+C3H5]
+ (or [M+ 41]+); [M+CH5]
+ (or [M+ 17]+) adduct ions
are not observed.
E-AC and A-AC are isomers at one ring junction (A/B) position,
where the hydrogen is 5b and 5a (Figure 1), respectively, result-
ing in very different structural conﬁgurations. The A/B ring
structure is cis (the A ring is angled out of the plane of ﬁgure)Drug Test. Analysis 2011, 3, 857–867 Copyright © 2011 John Wwhen the 5 position H is b (5b), and trans when 5a (the A ring
in the plane of the ﬁgure). Moreover, EpiA-AC is an isomer of
A-AC, where the functional group (in this case AC) is 3b and 3a,
respectively. The most notable comparison of these three ste-
roids is that each of their EI, PCI-CH4 and PCI-NH3 MS has gener-
ally the same pattern for all three (Figures 5a, 5d, 5g). PCI-CH4
(Figures 5b, 5e, 5h) provides no (pseudo)molecular ion, but
does result in acetate loss [MH-60] + ions (m/z 273) aiding in mo-
lecular weight assignment, when used along with the [MH-18] +
ions (m/z 315) indicating a 42 mass loss. PCI-NH3 results in
unambiguous molecular weight information through a 17 mass
loss observed by the pair of [MH] + (m/z 333) and [M+NH4]
+
(m/z 350) ion signals, in addition to structural information
through acetate loss [MH-60] + ions (m/z 273) indicating a mono-
acetate (Figures 5c, 5f, 5i). A-AC and EpiA-AC cannot be easily
differentiated through either MS; however, PCI-NH3 can be used
to differentiate E-AC and A-AC through the [M+NH4]
+ / [MH] +
ratio which is 14.3 and 5, respectively, as shown in Table 1. The
PCI-NH3 MS of the remaining endogenously relevant monoace-
tates (19NE-AC, DHEA-AC, 11KE-AC) also provided molecular
weight and acetate group information as shown in Figures , 6c,
6f, and 6i, respectively.
Two of the three analyzed diacetates, 5bA-diAC and 5aA-diAC,
are cis/trans isomers at the A/B ring junction at position 5,iley & Sons, Ltd. wileyonlinelibrary.com/journal/dta
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6respectively, while 5bP-diAC is A/B cis at position 5. Interestingly,
PCI-CH4 yields primarily the [MH-120]
+ ion for all three diacetates
at m/z 257 for 5aA-diAC and 5bA-diAC (Figures 7b and 7e) and
m/z 285 for 5bP-diAC (Figure 7h); these ions are less useful for
molecular weight and functional group information. In contrast,
PCI-NH3 (Figures 7c, 7f, 7i) provides strong adduct [M+NH4]
+ , sin-
gle acetate loss [MH-60]+, and double acetate loss [MH - 120] +
ions, together making molecular weight determination and
functional group assignment unambiguous. Alternatively, the
native 11-OHA is a steroid diol that was derivatized to form a
monoacetate (11OHA-AC; Steraloids Inc., Newport, RI, USA)
rather than a diacetate, which is interpretable and veriﬁed in
the PCI-NH3 MS (Figure 8c), with the presence of (pseudo) molec-
ular weight ions [M+NH4]
+ (m/z 366) and [MH] + (m/z 349) and
partial [MH-43]+ and full [MH-60]+ single acetate loss ions.
Otherwise, molecular weight is not directly obtained from the
PCI-CH4 MS (Figure 8b), but it does reveal evidence of just one
acetate group loss when comparing the [MH-60]+ and [MH-18]+
ions.
Overall, the order of the steroid PCI-NH3 MS [M +NH4]
+ /
[MH] + ratios (inﬁnite to 0.03 as shown in Table 1) followed as
(5bP-diAC, 5bA-diAC)> 5aA-diAC> E-AC> 11KE-AC>DHEA-AC> 5
-androstanol-AC>A-AC> 19NE-AC> EpiA-AC> (DHT-AC, 11-OHA-
3-AC)> (T-AC, EpiT-AC), and is inversely related to their PA. The
only compound in SM15-AC that yielded neither [M +NH4]
+
nor [MH] +, but rather M+, was Cne, a saturated steroid
precursor, as shown in Figure 8f and resembles the EI MS in
Figure 8d. In addition, because Cne has no hydroxyl groups, it
is not acetylated during derivatization.wileyonlinelibrary.com/journal/dta Copyright © 2011 JoConclusions
This work demonstrates GCGC coupled to qMS as a potential
new tool for steroid detection and proﬁling in complex urine
extracts. When used in combination with additional investigative
techniques, the high speciﬁcity of GCGC-(PCI-NH3)-qMS will be
helpful for identiﬁcation of unknown steroids in complex urine
matrices. PCI-NH3 produces simpler mass spectra and more
abundant pseudo molecular ion mass spectra than EI, allowing
straightforward interpretation for molecular weight and charac-
terization of steroid functional groups. The use of PCI-NH3, along
with EI, potentially allows detection and identiﬁcation of
unknown compounds, such as designer steroids, that elute in
unique retention spots in the 2D chromatogram, and potentially
more easily interpretable than with traditional 1D GC-MS
techniques.Acknowledgements
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